130 filings
Page 5 of 7
8-K
gdumnk7he80uo2nqzdq
18 May 20
Axcella Announces Pricing of Public Offering of Common Stock
4:17pm
424B4
dxu2no08fe6xar651c
14 May 20
Prospectus supplement with pricing info
5:15pm
EFFECT
1gj 9p0sz5
14 May 20
Notice of effectiveness
12:15am
8-K
2kqwga 4dqtn17z83
11 May 20
Axcella Reports First Quarter Financial Results and Provides Business Update
8:13am
CORRESP
cfrgvzpsn65tweun6l
11 May 20
Correspondence with SEC
12:00am
CORRESP
1jt8 i8p7
11 May 20
Correspondence with SEC
12:00am
8-K
kj8u26 hthzt2gmk
8 May 20
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
co8y2h0t28xho1ka87b
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DEFA14A
vubi6hcusf1804ms9eyz
4 May 20
Additional proxy soliciting materials
4:30pm
UPLOAD
94v6m
9 Apr 20
Letter from SEC
12:00am
DEFA14A
4t46y 3key
3 Apr 20
Additional proxy soliciting materials
4:19pm
DEF 14A
j7rk425z5zzi5smtgqa0
3 Apr 20
Definitive proxy
4:15pm
DRS
n2qrkg2n
3 Apr 20
Draft registration statement
12:00am
10-K
n34zvvrqc
23 Mar 20
Annual report
4:12pm
8-K
65s gg8zoq9i5i7rmw
23 Mar 20
Axcella Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business Update
4:03pm
8-K
ujbkmau90 4hx33aap
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
8-K
p1i9s7rt u5c0y
12 Nov 19
Results of Operations and Financial Condition
4:04pm